Logo-apb

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308 
pISSN: 2228-5881 

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by
Adv Pharm Bull. 2024;14(2): 253-254. doi: 10.34172/apb.2024.021
PMID: 39206393        PMCID: PMC11347732

Letter to Editor

Translational Challenges in Cancer Nanotherapy

Ammu V. V. V. Ravi Kiran 1 ORCID, Garikapati Kusuma Kumari 1 ORCID, Praveen T. Krishnamurthy 1 * ORCID, Bhadram Kalyan Chekreverthy 2 ORCID

Cited by CrossRef: 0

1- Zafar A, Alsaidan O, Mujtaba M. Nano-carriers based Approaches Loaded with Herbal Bioactive Compounds for the Treatment of Cancer: Recent Updates and Future Prospects. PRA. 2026;21(3):245 [Crossref]
2- Mostafa M, Mosallam S, Eltaweel M, Amin M, Abd El-Halim S. NSAIDs-loaded nanocarriers as emerging anticancer therapeutics: Harnessing inflammation-targeted drug delivery to combat tumor progression. International Journal of Pharmaceutics. 2026;694:126751 [Crossref]
3- Chandrasekaran S, Duraisamy N, Jagadeesan M, Palukuri Y, Tamilselvan S. Engineering CRISPR nanoplatforms to deplete cancer stem cells: Delivery checkpoints, target plasticity, and clinical viability. Nanomedicine: Nanotechnology, Biology and Medicine. 2026;76:103007 [Crossref]
4- Saxena S, Sharma S, Kumar G, Thakur S. Unravelling the complexity of CARPA: a review of emerging advancements in therapeutic strategies. Arch Dermatol Res. 2025;317(1) [Crossref]
5- Szwed M, Poczta-Krawczyk A, Bukowski K, Marczak A. Nanoparticle-Mediated Ferroptosis for Cancer Therapy: Mechanisms and Therapeutic Strategies. NSA. 2025;Volume 18:445 [Crossref]